You can buy or sell TCON and other stocks, options, ETFs, and crypto commission-free!
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treatment of fibrotic diseases; and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. Read More The company was founded in October 2004 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Expected Nov 6, After Hours